alexa Magnetic Fe3O4-based Nanoparticles As Drug Delivery Systems For Targeted Cancer Therapy
ISSN: 2161-0444

Medicinal Chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

5th International Conference on Medicinal Chemistry & Computer Aided Drug Designing and Drug Delivery
December 05-07, 2016 Phoenix, USA

Juan Wu, Wei Jiang, Fengsheng Li, Yewen Shen, Wei Jiang and Renbing Tian
Nanjing University of Science and Technology, China
Posters & Accepted Abstracts: Med chem
DOI: 10.4172/2161-0444.C1.028
Abstract
The development of tumor specific multifunctional nanoparticles for targeted and efficient delivery of drugs to tumor cells is currently an area of intense research with the potential to revolutionize the treatment of cancer. As a major class of nanoparticles, magnetic iron oxide nanoparticles have been examined extensively for applications in cancer therapy due to their ultra-fine size, biocompatibility and magnetic properties. In addition, the pH value of most solid tumors (pH<6.0) was lower than the surrounding normal tissues (pH 7.4). Therefore, in our work, we developed and prepared two different Fe3O4- based doxorubicin (DOX) delivery systems and the drug loading modes were chemical bond (system I) and electrostatic adsorption (system II), respectively. In system I, Fe3O4 nanoparticles were coated by polyethyleneglycol (PEG) used as surfacemodifying agent and polyethyleneimine (PEI) used as the drug-loading site via a one-pot pyrolysis method. The prepared carriers were within 20 nm and had good stability in dispersion and super-paramagnetic properties. DOX was grafted to [email protected] at a loading rate of up to 85% via the reaction between the 13-carbonyl of DOX and the primary amine of PEI. During in vitro release studies, nearly 81% DOX was released from the system within 72 h at pH 4.5, compared with only 28% at pH 7.4. For system II, DOX was loaded onto recyclable clusters of Fe3O4 nanoparticles at a loading rate of 76.19% by electrostatic interaction which has desirable pH-responsivity usually exhibits easier operation in experimental procedure, and lower consumption and pollution. Moreover, the release studies in vitro showed that the system II had excellent pH-sensitivity, 76.16% of DOX was released within 72 h at pH 4.0, and the secondary drug loading rate was nearly 52%. WST-1 assays in model breast cancer cells (MCF-7) demonstrated that system II exhibited high anti-tumor activity, while the recyclable clusters of Fe3O4 nanoparticles were practically non-toxic. Our results revealed that both system I and system-II would be a competitive candidate for targeted cancer therapy in the near future. While in the case of the little difference of drug loading rate and the release rate between system I and system II, the latter would be even better due to its environmentally friendly drug loading mode and the recyclable drug loading performance.
Biography

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords